| 1 | [SID51085112] | Active | EC50 | 3.62 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | EC50 | 3.62 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 2 | [SID51085112] | Active | EC50 | 4.634 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | EC50 | 4.634 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID51085112] | Active | EC50 | 6.559 | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression [AID1914, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | EC50 | 6.559 [uM] | | BioAssay | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression | | AID | 1914 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 4 | [SID51085112] | Active | EC50 | 8.157 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | EC50 | 8.157 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID51085112] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID51085112] | Active | Potency | 10.4179 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 10.4179 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID51085112] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID51085112] | Active | Potency | 16.3601 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 9 | [SID51085112] | Active | Potency | 22.3872 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 10 | [SID51085112] | Active | Potency | 22.3872 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 11 | [SID51085112] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 12 | [SID51085112] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 13 | [SID51085112] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 14 | [SID51085112] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 15 | [SID51085112] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 16 | [SID51085112] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 17 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 18 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 19 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 20 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 21 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 22 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 23 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 24 | [SID51085112] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 25 | [SID51085112] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 26 | [SID51085112] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 27 | [SID51085112] | Active | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 28 | [SID51085112] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) [AID2358, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) | | AID | 2358 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 29 | [SID51085112] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 30 | [SID51085112] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 31 | [SID51085112] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 32 | [SID51085112] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 33 | [SID51085112] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 34 | [SID51085112] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 35 | [SID51085112] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 36 | [SID51085112] | Active | | | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) [AID434939, Type: screening] | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) | | AID | 434939 | | BioAssay type | screening | | Target | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] | | PubMed | | | Data Table |  |
|
| 37 | [SID51085112] | Active | | | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) [AID434939, Type: screening] | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) | | AID | 434939 | | BioAssay type | screening | | Target | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] | | PubMed | | | Data Table |  |
|
| 38 | [SID51085112] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 39 | [SID51085112] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 40 | [SID51085112] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 41 | [SID51085112] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 42 | [SID51085112] | Active | | | MLPCN Streptokinase Expression Inhibition [AID1662, Type: screening] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | MLPCN Streptokinase Expression Inhibition | | AID | 1662 | | BioAssay type | screening | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 43 | [SID51085112] | Active | | | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) [AID624371, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) | | AID | 624371 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 44 | [SID51085112] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 45 | [SID51085112] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID51085112] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID51085112] | Inactive | Potency | 8.9125 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Inactive | | Potency | 8.9125 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID51085112] | Inactive | Potency | 22.3872 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 49 | [SID51085112] | Inactive | Potency | 25.1189 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 50 | [SID51085112] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51085112 | | CID | 24891772 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|